You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Express Scripts
Moodys
Merck
McKinsey

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Litigation Details for Semcon IP Inc. v. Louis Vuitton North America, Inc. (E.D. Tex. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Semcon IP Inc. v. Louis Vuitton North America, Inc. (E.D. Tex. 2019)

Docket   Start Trial Date Filed 2019-04-15
Court District Court, E.D. Texas Date Terminated
Cause 15:1126 Patent Infringement Assigned To James Rodney Gilstrap
Jury Demand Both Referred To
Parties LOUIS VUITTON NORTH AMERICA, INC.; SEMCON IP INC.; TCL COMMUNICATION TECHNOLOGY HOLDINGS LIMITED; TCT MOBILE INTERNATIONAL LIMITED
Patents 10,004,700; 10,004,742; 10,005,783; 10,007,766; 10,010,517; 10,016,415; 10,017,742; 10,022,509; 10,028,858; 10,028,910; 10,030,060; 10,035,766; 10,035,848; 10,039,757; 10,039,758; 10,039,910; 10,040,783; 10,040,848; 10,040,859; 10,045,532; 10,046,288; 10,052,381; 10,058,523; 10,058,546; 10,059,771; 10,064,875; 10,064,901; 10,064,911; 10,064,913; 10,071,358; 10,076,523; 10,080,725; 10,086,047; 10,086,080; 10,086,156; 10,098,744; 10,098,910; 10,115,318; 10,172,516; 10,172,861; 10,172,875; 10,322,080; 10,322,085; 10,322,086; 10,322,193; 10,329,331; 10,329,546; 10,342,771; 10,342,778; 10,342,859; 10,342,875; 10,381,112; 10,391,055; 10,391,075; 10,391,085; 10,391,100; 10,400,026; 10,400,247; 10,415,014; 10,415,033; 10,509,043; 10,532,028; 10,532,051; 10,532,056; 10,532,076; 10,532,096; 10,532,098; 10,596,112; 6,004,596; 6,007,439; 6,008,437; 6,010,417; 6,010,911; 6,030,299; 6,030,778; 6,051,561; 6,063,771; 6,074,684; 6,080,913; 6,156,742; 6,329,156; 6,437,099; 6,439,572; 6,561,046; 6,566,135; 6,689,073; 6,689,566; 6,750,019; 6,758,771; 6,858,596; 6,861,243; 6,967,028; 6,979,437; 7,014,861; 7,018,806; 7,038,071; 7,059,862; 7,060,875; 7,064,243; 7,112,439; 7,122,566; 7,172,751; 7,247,318; 7,262,019; 7,262,342; 7,329,070; 7,329,725; 7,391,021; 7,415,858; 7,417,042; 7,417,067; 7,417,070; 7,439,057; 7,566,705; 7,572,197; 7,572,783; 7,700,081; 7,700,299; 7,700,561; 7,700,742; 7,748,038; 7,750,023; 7,757,417; 7,858,070; 7,858,122; 7,858,390; 7,875,342; 7,910,758; 7,913,036; 7,967,011; 8,003,627; 8,007,381; 8,007,806; 8,017,390; 8,017,758; 8,021,875; 8,029,391; 8,029,783; 8,039,627; 8,067,437; 8,071,546; 8,073,627; 8,075,911; 8,158,156; 8,193,400; 8,247,007; 8,247,400; 8,288,085; 8,299,046; 8,299,052; 8,299,057; 8,299,081; 8,299,108; 8,318,750; 8,318,758; 8,329,172; 8,329,778; 8,415,342; 8,415,400; 8,546,437; 8,561,859; 8,574,102; 8,574,858; 8,669,051; 8,708,437; 8,742,076; 8,748,113; 8,758,075; 8,771,758; 8,778,390; 8,778,911; 8,859,023; 8,859,509; 8,859,572; 8,859,748; 8,901,086; 8,901,299; 9,011,391; 9,012,437; 9,023,391; 9,023,417; 9,023,783; 9,027,967; 9,028,243; 9,029,509; 9,034,370; 9,034,390; 9,034,391; 9,050,262; 9,050,322; 9,051,561; 9,060,532; 9,060,708; 9,061,052; 9,062,158; 9,062,331; 9,067,113; 9,072,742; 9,072,744; 9,073,858; 9,074,122; 9,075,057; 9,085,627; 9,090,517; 9,090,689; 9,090,700; 9,090,705; 9,095,391; 9,095,509; 9,096,861; 9,102,742; 9,113,627; 9,115,342; 9,156,859; 9,180,090; 9,180,095; 9,180,096; 9,180,172; 9,180,197; 9,192,112; 9,192,596; 9,193,757; 9,194,011; 9,194,859; 9,243,025; 9,243,053; 9,243,058; 9,299,158; 9,322,008; 9,322,025; 9,322,034; 9,322,048; 9,322,067; 9,381,243; 9,381,247; 9,388,243; 9,415,004; 9,415,007; 9,415,008; 9,415,009; 9,415,029; 9,415,043; 9,415,050; 9,415,053; 9,415,085; 9,415,098; 9,415,102; 9,415,103; 9,439,901; 9,439,911; 9,517,023; 9,517,439; 9,523,099; 9,561,068; 9,561,073; 9,561,080; 9,561,197; 9,561,243; 9,561,288; 9,561,331; 9,561,417; 9,566,243; 9,566,331; 9,572,861; 9,574,010; 9,669,008; 9,669,009; 9,669,023; 9,669,024; 9,669,026; 9,669,068; 9,669,074; 9,669,096; 9,669,108; 9,689,015; 9,700,050; 9,700,561; 9,708,342; 9,708,391; 9,708,400; 9,750,684; 9,751,859; 9,757,437; 9,758,561; 9,771,358; 9,861,708; 9,861,757; 9,861,771; 9,901,113; 9,910,046; 9,913,901; 9,913,910; 9,967,068
Attorneys Alexander P. Ott; Alfred Ross Fabricant; Calli A Turner; David H Bluestone; Enrique William Iturralde; Jiaxiao Zhang; Justin Kurt Truelove; Justine Minseon Park; Melissa Richards Smith; Peter Lambrianakos; Shahar Harel; Vincent J Rubino , III
Firms Barack Ferrazzano Kirschbaum and Nagelberg LLP; Brown Rudnick LLP NY; Gillam and Smith LLP; McDermott Will & Emery LLP - Dallas; McDermott Will & Emery LLP - DC; McDermott Will & Emery LLP - Irvine; Truelove Law Firm
Link to Docket External link to docket
Small Molecule Drugs cited in Semcon IP Inc. v. Louis Vuitton North America, Inc.
Biologic Drugs cited in Semcon IP Inc. v. Louis Vuitton North America, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Semcon IP Inc. v. Louis Vuitton North America, Inc. (E.D. Tex. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-04-29 62 Memorandum & Opinion e.g., Seymour v. Osborne, 11 Wall. 516, 546 (1871) (a patent may be “so interspersed with technical…processor” • ’627 Patent Claims 1, 2, 4, 10, 11, 12 • ’247 Patent Claims 2, 3, 4, 10, 14, 15, 17, … • ’627 Patent Claims 1, 2, 4, 10, 11, 12 • ’247 Patent Claims 2, 3, 4, 10, 14, …and ordinary meaning • ’627 Patent Claim 10 • ’247 Patent Claims 3, 4, 14, 15, 21, 22 …specified by • ’061 Patent Claim 10 an input” • ’627 Patent Claim 25 “programmable External link to document
2020-05-19 85 Memorandum & Opinion processor” • ’627 Patent Claims 1, 2, 4, 10, 11, 12 • ’247 Patent Claims 2, 3, 4, 10, 14, 15, 17, … • ’627 Patent Claims 1, 2, 4, 10, 11, 12 • ’247 Patent Claims 2, 3, 4, 10, 14, … ordinary meaning • ’627 Patent Claim 10 • ’247 Patent Claims 3, 4, 14, 15, 21, 22 “frequency … • ’627 Patent Claim 10 • ’247 Patent Claims 3, 4, 14, 15, 21, …’061 Patent File Wrapper September 3, 2004 Reply to Action Closing Prosecution at 2, 4, 6, 8, 10, 17, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
McKinsey
Johnson and Johnson
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.